All News

Welcome to the new look and branding of Pharmaceutical Executive-reimagined to better reflect you, our audience, and expand on the content you've long trusted us to deliver.

ZS offers advice to ensure reps can stay engaged with their customers during these times of changing needs and constraints.

Now officially a worldwide pandemic, the biomedical research community is rushing to develop treatments and preventives to halt the spread and severity of the COVID-19 virus.

Click the title above to open the Pharmaceutical Executive March 2020 issue in an interactive PDF format.

High customer satisfaction and low risk is the goal for patient service programs and is possible with focus on solid service delivery and quality.

The continued COVID-19 outbreak has fueled fears of drug shortages, primarily for active pharmaceutical ingredients produced in China.

With the nomination period for our latest Emerging Pharma Leaders selections in full swing, it's a good reminder that the industry's future path ultimately depends on its leaders, emerging and otherwise.

Key learnings from the BCG Market Access benchmark 2019.

Click the title above to open the Pharmaceutical Executive February 2020 issue in an interactive PDF format.

Hungary is fast staking a reputation for itself as one of Central and Eastern Europe’s most dynamic economies. A major factor has been pharmaceuticals, where Hungary’s history of research and production is reflected today in an attractive pharma investment landscape and the presence of home-grown success stories.

Guidelines on how innovators can assert patents to protect their products’ exclusivity while avoiding claims from competitors and the FTC that their conduct runs afoul of U.S. antitrust law.